Lido Advisors’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$251K Sell
4,000
-2,500
-38% -$200K ﹤0.01% 1665
2025
Q4
$620K Hold
6,500
﹤0.01% 1213
2025
Q3
$635K Hold
6,500
﹤0.01% 1140
2025
Q2
$698K Buy
+6,500
New +$658K ﹤0.01% 986

Other funds holding BSX

Lido Advisors's BSX Position: Q1 2026 in Review

Lido Advisors reduced its Boston Scientific (BSX) stake by 7.9% in Q1 2026, selling an estimated $892K and leaving 129,133 shares worth $8.1M. The position accounts for 0.02% of the portfolio, ranked #358.

Lido Advisors first reported a position in BSX in Q2 2019 and has held it in 28 quarters since. The position peaked at $13.9M in Q1 2025. 1,664 funds tracked by Wall St. Rank hold BSX as of Q1 2026.

  • Lido Advisors held 129,133 shares of Boston Scientific worth $8.1M as of Q1 2026.
  • Lido Advisors sold 11,149 Boston Scientific shares in Q1 2026, an estimated $892K.
  • Boston Scientific made up 0.02% of Lido Advisors's portfolio in Q1 2026, its #358 holding.
  • Lido Advisors first reported a position in Boston Scientific in Q2 2019 and has held it in 28 quarters since.
  • Lido Advisors's Boston Scientific position peaked at $13.9M in Q1 2025.
  • 1,664 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2026.

Based on Lido Advisors's 13F filing for Q1 2026, filed 13 May 2026.